4.8.9Segment

Ophthalmology & Vision Devices

Medical devices for cataract surgery, refractive correction, glaucoma treatment, and retinal care used by ophthalmologists and ophthalmic surgery centers.

5
Verticals

Overview

Ophthalmology & Vision Devices covers medical devices for cataract surgery, refractive correction, glaucoma treatment, and retinal care, used by ophthalmologists and ophthalmic surgery centers. The market is led by Alcon and Johnson & Johnson Vision, with intraocular lenses (IOLs), surgical equipment, and minimally invasive glaucoma surgery (MIGS) as key categories.

Demand is driven by the aging population and rising cataract and retinal procedure volumes, with premium IOLs a higher-value growth area. It is a consolidated, innovation-driven category combining capital equipment, implants, and consumables.

Market snapshot

Market size
~$6.5B
Growth
~1.1%CAGR (2017–22, nominal)
Companies
~300 firms
Firms by employee count

73.7% of firms have fewer than 20 employees: 221 micro-businesses, below most mandates.

The investable universe79 firms with 20+ employees
20–99
4759%
100–499
1215%
500+
2025%

~300 makers of intraocular lenses, cataract and refractive equipment, and glaucoma devices, led by Alcon and J&J Vision. Aging-driven cataract volumes and premium IOLs support demand, though measured growth was flat (~1%/yr). The code captures broader ophthalmic goods, and with only 20 firms over 500 employees the strategic-buyer pool is thin — exits skew sponsor-to-sponsor.

NAICS 339115. U.S. Census Bureau — 2022 Statistics of U.S. Businesses; U.S. Census Bureau — 2022 Economic Census.

Business model & economics

Revenue model

Implants, equipment, and consumables for eye care

Key economics

Revenue per firm
$21,707,953
Revenue per employee
$303,778
Employees per firm
73.7
Recurring revenue
Moderate

procedure-driven implants and consumables

EBITDA margin
18–28%
Capex intensity
High

Characteristics

  • Scale-driven — payroll is only 22% of revenue; the cost base is assets, not headcount
  • Thin strategic-buyer pool — only 20 firms exceed 500 employees; exits skew sponsor-to-sponsor
  • Aging-driven cataract and retinal procedure growth.
  • Premium IOLs a higher-value growth area.
  • Led by Alcon and J&J Vision.

NAICS 339115. U.S. Census Bureau — 2022 Statistics of U.S. Businesses; U.S. Census Bureau — 2022 Economic Census.

Geographic concentration

AlabamaAlaskaArizonaColoradoFloridaIndianaKansasMaineMassachusettsNew JerseyNorth CarolinaNorth DakotaOklahomaPennsylvaniaSouth DakotaTexasWyomingConnecticutMissouriWest VirginiaIllinoisNew MexicoCaliforniaDelawareDistrict of ColumbiaHawaiiIowaKentuckyMarylandMichiganMississippiMontanaNew HampshireNew YorkOhioOregonTennesseeUtahVirginiaWashingtonWisconsinSouth CarolinaIdahoNevadaVermontLouisianaRhode IslandGeorgiaMinnesotaArkansasNebraska

Ophthalmology and vision-device manufacturing over-indexes by employment in Minnesota, Arkansas, Nebraska, and Georgia, reflecting concentrated device-maker operations.

MinnesotaArkansasNebraskaGeorgia

U.S. Census Bureau — 2022 County Business Patterns (employment by state), NAICS 339115. Concentration shown by location quotient.

M&A deal context

Deal activityModerate

Who’s acquiring

  • Ophthalmic-device strategics
  • Diversified medtech platforms
  • VC-backed innovators

What’s driving deals

  • Premium-IOL and MIGS innovation.
  • Aging-demographic procedure demand.
  • Acquisition of ophthalmic innovation.

Verticals in this segment

Find Ophthalmology & Vision Devices acquisition targets

Search Acquisera’s index for companies classified under Ophthalmology & Vision Devices (4.8.9) and build a targeted deal pipeline.

Search companies